Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice
Open Access
- 31 December 1994
- Vol. 12 (3), 279-285
- https://doi.org/10.1016/0264-410x(94)90206-2
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATIONAnnual Review of Microbiology, 1990
- Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia virusesArchiv für die gesamte Virusforschung, 1990
- Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2bJournal of General Virology, 1990
- Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity.The Journal of Experimental Medicine, 1989
- Molecular Characterization of a Neutralizing Domain of the Japanese Encephalitis Virus Structural GlycoproteinJournal of General Virology, 1989
- Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cellsVirology, 1989
- Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.Journal of Clinical Investigation, 1989
- Protection of Mice Against Dengue 2 Virus Encephalitis by Immunization with the Dengue 2 Virus Non-structural Glycoprotein NS1Journal of General Virology, 1987
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Experimental Studies on Dengue: I. Isolation, Identification and Modification of the VirusThe Journal of Infectious Diseases, 1952